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Abstract 
Protein tyrosine phosphorylation is thought to be important for regulation of the 
proliferation, differentiation, and rapid turnover of intestinal epithelial cells (IECs). The 
role of protein tyrosine phosphatases in such homeostatic regulation of IECs has 
remained largely unknown, however. Src homology 2–containing protein tyrosine 
phosphatase (Shp2) is a ubiquitously expressed cytoplasmic protein tyrosine 
phosphatase that functions as a positive regulator of the Ras–mitogen-activated protein 
kinase (MAPK) signaling pathway operative downstream of the receptors for various 
growth factors and cytokines, and it is thereby thought to contribute to the regulation of 
cell proliferation and differentiation. We now show that mice lacking Shp2 specifically 
in IECs (Shp2 CKO mice) develop severe colitis and die as early as 3 to 4 weeks after 
birth. The number of goblet cells in both the small intestine and colon of Shp2 CKO 
mice was markedly reduced compared with that for control mice. Furthermore, Shp2 
CKO mice showed marked impairment of both IEC migration along the crypt-villus 
axis in the small intestine and the development of intestinal organoids from isolated 
crypts. The colitis as well as the reduction in the number of goblet cells apparent in 
Shp2 CKO mice were normalized by expression of an activated form of K-Ras in IECs. 
Our results thus suggest that Shp2 regulates IEC homeostasis through activation of Ras 
and thereby protects against the development of colitis. 
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Introduction 
Intestinal epithelial cells (IECs) play a central role in the absorption of nutrients and 
water by the intestine as well as contribute to protection against ingested pathogens by 
providing a functional barrier. In mammals, IECs of the small and large intestine are 
regenerated continuously from stem cells throughout adulthood [1]. The stem cells that 
give rise to IECs reside in a region near the base of intestinal crypts. These stem cells 
generate proliferating progeny, known as transient amplifying (TA) cells, that migrate 
out of the stem cell niche, cease to proliferate, and initiate differentiation into the 
various cell lineages of mature intestinal villi, including absorptive enterocytes, 
mucin-secreting goblet cells, peptide hormone–secreting neuroendocrine cells, and 
antimicrobial peptide–producing Paneth cells [2]. Cells of the first three of these four 
lineages mature and migrate up the crypt toward the tip of intestinal villi, whereas 
Paneth cells travel down to the base of the crypt. Absorptive enterocytes in particular 
have a short life span, being released into the gut lumen after they have migrated to the 
tip of the villi. Such elimination of IECs is thought to be triggered by either spontaneous 
apoptosis [3] or overcrowding [4] of IECs, although the mechanism by which the 
precise timing of elimination is determined remains poorly understood. The continuous 
production of new IECs from each crypt is thus balanced by the elimination of older 
cells at the luminal side of the intestine, resulting in a rapid turnover of IECs (4 to 5 
days in the mouse) [1,2].  
Protein tyrosine phosphorylation is an important signaling mechanism that 
regulates the proliferation, differentiation, migration, and survival of IECs. For instance, 
epidermal growth factor (EGF), whose receptor is a protein tyrosine kinase (PTK), is 
thought to be essential for IEC proliferation [5]. In addition, ephrins and their PTK 
receptors are implicated in the proliferation of intestinal stem cells and the positioning 
of IECs along the crypt-villus axis [1,6,7]. In contrast to PTKs, the importance of 
protein tyrosine phosphatases (PTPs) in the regulation of IECs has remained largely 
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unknown, with the exception that stomach cancer–associated protein tyrosine 
phosphatase–1 (SAP-1, also known as PTPRH), a receptor-type PTP, is specifically 
expressed in IECs [8] and might play a role in control of the proliferation or migration 
of these cells [9].  
Src homology 2–containing protein tyrosine phosphatase 2 (Shp2, also known as 
PTPN11) is a cytoplasmic PTP that contains two tandem Src homology 2 (SH2) 
domains [10,11]. Shp2 is expressed in most mammalian cell types and is thought to 
bind through its SH2 domains to the tyrosine-phosphorylated platelet-derived growth 
factor (PDGF) receptor as well as to tyrosine-phosphorylated docking proteins (such as 
insulin receptor substrates, signal regulatory protein α, and Grb2-associated binder 
proteins) in response to cell stimulation with growth factors or to cell adhesion. Such 
binding is important both for activation of the PTP activity of Shp2 as well as for its 
recruitment to sites near the plasma membrane where potential substrates are located 
[10,11]. Although PTPs are generally considered to be negative regulators on the basis 
of their ability to oppose the effects of PTKs, biochemical and genetic analyses indicate 
that Shp2 is required for activation of the Ras–mitogen-activated protein kinase 
(MAPK) signaling pathway operative downstream of the receptors for various growth 
factors and cytokines, and that it thereby contributes to the promotion of cell 
proliferation, differentiation, or survival [10,11]. Moreover, Shp2 is also implicated in 
the regulation of cell adhesion and migration, in part through its control of the activity 
of the small GTP-binding protein Rho [12,13]. Indeed, homozygous Shp2 mutant mice 
were found to die as embryos as a result of a defect in gastrulation and abnormal 
mesoderm patterning [14].  
The precise role of Shp2 in the regulation of IEC function, especially in vivo, has 
remained unclear, however. To address this issue, we have now generated and analyzed 
IEC-specific Shp2 conditional knockout (CKO) mice.  
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Materials and Methods 
Ethics Statement 
This study was approved by the Institutional Animal Care and Use Committee of Kobe 
University (Permit Number: P130206, P120304-R2, P110402), and all animal 
experiments were performed according to Kobe University Animal Experimentation 
Regulations. All efforts were made to minimize suffering. 
Antibodies and reagents  
A mouse monoclonal antibody (mAb) to β-catenin was obtained from BD Biosciences 
(San Diego, CA), a mouse mAb to β-tubulin was from Sigma-Aldrich (St. Louis, MO), 
and a rat mAb to bromodeoxyuridine (BrdU) was from Abcam (Cambridge, MA). 
Rabbit polyclonal antibodies (pAbs) to Shp2 and to mucin 2 were obtained from Santa 
Cruz Biotechnology (Santa Cruz, CA), those to lysozyme were from Dako (Glostrup, 
Denmark), and those to cleaved caspase-3 (Asp175) were from Cell Signaling 
Technology (Danvers, MA). Alkaline phosphatase–conjugated sheep pAbs to 
digoxigenin for in situ hybridization were obtained from Roche (Basel, Swizerland). 
Cy3- or Alexa Fluor 488–conjugated goat secondary pAbs for immunofluorescence 
analysis were obtained from Jackson ImmunoResearch (West Grove, PA) and 
Invitrogen (Carlsbad, CA), respectively, and 4',6-diamino-2-phenylindole (DAPI) was 
from Nacalai Tesque (Kyoto, Japan). Horseradish peroxidase–conjugated goat 
secondary pAbs for immunoblot analysis were obtained from Jackson ImmunoResearch. 
Mayer’s hemalum solution was from Merck KGaA (Darmstadt, Germany), and eosin 
was from Wako (Osaka, Japan).  
Mice  
Ptpn11fl/fl mice were kindly provided by Dr. B. G. Neel (Princess Margaret Cancer 
Centre) [15]. The Rosa26 conditional reporter strain (R26R) of mice 
(B6.129S4-Gt(ROSA)26Sortm1Sor/J) [16], LSL-Kras G12D mice (B6.129S4-Krastm4Tyj/J) 
[17], and villin-cre mice (B6.SJL-Tg(Vil-cre)997Gum/J) [18] were obtained from 
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Jackson Laboratory (Bar Harbor, ME). R26R;villin-cre mice were obtained by crossing 
R26R mice with villin-cre mice. To generate Ptpn11fl/+;villin-cre mice, we crossed 
villin-cre mice with Ptpn11fl/fl mice. The resulting Ptpn11fl/+;villin-cre offspring were 
crossed with Ptpn11fl/fl mice to obtain Ptpn11fl/fl;villin-cre (Shp2 CKO) mice and 
Ptpn11fl/fl (control) mice. To generate Ptpn11fl/+;villin-cre;LSL-Kras G12D mice, we 
crossed Shp2 CKO mice with LSL-Kras G12D mice. The resulting 
Ptpn11fl/+;villin-cre;LSL-Kras G12D offspring were crossed with Ptpn11fl/fl mice to 
obtain Ptpn11fl/fl;villin-cre;LSL-Kras G12D (Shp2 CKO;LSL-Kras G12D) mice and 
Shp2 CKO mice. All mice were maintained in the Institute for Experimental Animals at 
Kobe University Graduate School of Medicine under specific pathogen–free conditions. 
The genotype of all offspring was determined by polymerase chain reaction (PCR) 
analysis.  
Detection of deleted and floxed alleles of Ptpn11 by PCR 
For preparation of genomic DNA, various tissues isolated from adult control or Shp2 
CKO mice were washed with ice-cold phosphate-buffered saline (PBS), incubated 
overnight at 56°C in lysis buffer (100 mM Tris-HCl [pH 8.5], 5 mM EDTA, 0.2% SDS, 
200 mM NaCl, proteinase K [50 μg/ml]), and centrifuged at 17,500 × g for 15 min at 
4°C. The resulting supernatant was subjected to isopropanol precipitation for separation 
of genomic DNA. The floxed Ptpn11 allele (~400-bp product) was identified by PCR 
with the sense primer SHP2F (5'-TAGCTGCTTTAACCCTCTGTGT-3') and the 
antisense primer SHP2R (5'-CATCAGAGCAGGCCATATTCC-3'), whereas the 
deleted allele (~500-bp product) was identified with the sense primer SHP2F and the 
antisense primer SHP2R#3 (5'-TCACAATGAAGGTTCCTGTCC-3'). 
Isolation of mouse IECs 
Mouse IECs were isolated as previously described [19] but with slight modifications. In 
brief, the freshly isolated whole intestine of adult control or Shp2 CKO mice was 
washed with PBS, cut into small pieces, washed three times with Hanks’ balanced salt 
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solution (HBSS) containing 1% fetal bovine serum and 25 mM HEPES-NaOH (pH 7.5), 
and then incubated three or four times on a rolling platform for 15 min at room 
temperature in HBSS containing 50 mM EDTA and 25 mM HEPES-NaOH (pH 7.5). 
The tissue debris was removed, and IECs in the resulting supernatant were isolated by 
centrifugation at 250 × g for 10 min at 4°C and washed three times with PBS.  
Immunoblot analysis 
Isolated cells or tissues were washed with ice-cold PBS and then homogenized on ice in 
RIPA buffer (20 mM Tris-HCl [pH 7.5], 150 mM NaCl, 2 mM EDTA, 1% Nonidet 
P-40, 1% sodium deoxycholate, 0.1% SDS, 50 mM NaF) containing 1 mM sodium 
vanadate and a protease inhibitor cocktail (Nacalai Tesque). The lysates were 
centrifuged at 17,500 × g for 15 min at 4°C, and the resulting supernatants were 
subjected to immunoblot analysis as previously described [8,19].  
Assessment of colitis  
For assessment of colitis, Shp2 CKO and control mice were weighed weekly and 
monitored for the appearance of diarrhea, blood in the stool, and anorectal prolapse. 
Disease activity was scored as previously described [20,21] with minor modifications. 
Stool consistency was scored as: 0 = normal, 2 = loose stools, 4 = liquid stools. Blood in 
the stool was scored as: 0 = no blood as revealed with the guaiac occult blood test 
(Occult Blood Slide II; Shionogi Pharmaceutical, Osaka, Japan), 2 = positive guaiac 
occult blood test, 4 = gross bleeding. Development of anorectal prolapse was scored as: 
0 = no prolapse, 2 = prolapse evident only during defecation, 4 = prolapse evident at all 
times. The total score for diarrhea, blood in the stool, and prolapse, ranging from 0 
(normal) to 12 (severe), was determined as the disease activity index (DAI). 
Histology and immunofluorescence analysis 
For histological analysis, the small intestine and colon were removed and immediately 
fixed for 3 h at room temperature with 4% paraformaldehyde in PBS. 
Paraffin-embedded sections (thickness of 5 μm) were then prepared and stained with 
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hematoxylin-eosin. For immunofluorescence analysis, the small intestine or colon was 
fixed as for histology and then transferred to a series of sucrose solutions (7, 20, and 
30% [w/v], sequentially) in PBS for cryoprotection, embedded in OCT compound 
(Sakura, Tokyo, Japan), and rapidly frozen in liquid nitrogen. Frozen sections with a 
thickness of 5 μm were prepared with a cryostat, mounted on glass slides, and air-dried. 
The sections were then subjected to immunofluorescence analysis with primary 
antibodies and fluorescent dye–labeled secondary antibodies as described previously [8]. 
Images were obtained with a fluorescence microscope (BX51; Olympus, Tokyo, Japan).  
β-Galactosidase staining 
Staining for β-galactosidase was performed as previously described [22] with slight 
modifications. In brief, the colon and small intestine were removed, fixed for 30 min at 
4°C with 0.2% glutaraldehyde and 4% paraformaldehyde in PBS, and washed with PBS. 
The tissue was then transferred to a series of sucrose solutions (7, 20, and 30% [w/v], 
sequentially) in PBS, embedded in OCT compound, and rapidly frozen with liquid 
nitrogen. Frozen sections with a thickness of 10 μm were prepared and then stained for 
2 to 10 h at 37°C with β-galactosidase substrate (X-gal [1 mg/ml], 4 mM K3Fe(CN)6, 4 
mM K4Fe(CN)6-3H2O, 2 mM MgCl2) in PBS. Stained sections were examined with a 
fluorescence microscope (BX51, Olympus). 
In situ hybridization 
Expression of the Olfactomedin4 (Olfm4) gene in the intestinal epithelium was 
examined by in situ hybridization performed as described previously [23]. In brief, 
paraffin-embedded sections of the ileum (thickness of 10 μm) were depleted of paraffin 
with xylene, rehydrated by exposure to a graded series of ethanol solutions, and treated 
with 0.2 M HCl and proteinase K. The sections were then fixed again with 4% 
paraformaldehyde, demethylated with acetic anhydride, and subjected to hybridization 
for 48 h at 65°C with a digoxigenin-labeled RNA probe for Olfm4 mRNA (IMAGE 
clone 1078130) at 500 ng/ml. They were then incubated overnight at 4°C with alkaline 
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phosphatase–conjugated pAbs to digoxigenin, washed, and incubated with nitro blue 
tetrazolium chloride and 5-bromo-4-chloro-3-indolyl phosphate (Sigma-Aldrich). 
Images were obtained with a fluorescence microscope (BX51, Olympus). 
BrdU incorporation assay 
Mice were injected intraperitoneally with BrdU (50 mg/kg) and killed 2 or 48 h later. 
The ileum or colon was fixed with 4% paraformaldehyde, transferred to a series of 
sucrose solutions in PBS, embedded in OCT compound, and rapidly frozen with liquid 
nitrogen as described for immunofluorescence analysis. Sections with a thickness of 5 
μm were incubated for 30 min at 65°C with 0.025 M HCl, washed with 0.1 M borate 
buffer (pH 8.5), and incubated at room temperature first for 2 h with mAbs to BrdU and 
to β-catenin and then for 1 h at with fluorescent dye–labeled secondary pAbs. 
Fluorescence images were obtained with a fluorescence microscope (BX51, Olympus). 
IEC migration distance was defined as the distance from the crypt base to the farthest 
migrated BrdU-positive cells and was measured with the use of ImageJ software (NIH). 
Intestinal organoid culture 
Intestinal organoid culture was performed as previously described [5]. In brief, crypts 
were isolated from the small intestine by incubation for 30 min in PBS containing 2 mM 
EDTA. The isolated crypts were mixed with Matrigel (BD Biosciences) and transferred 
to 48-well plates. After polymerization of the Matrigel, advanced Dulbecco’s modified 
Eagle’s medium–F12 (Invitrogen), which was supplemented with 
penicillin-streptomycin (100 U/ml) (Invitrogen), 10 mM HEPES (Invitrogen), 1× 
GlutaMAX (Invitrogen), 1× N2 (Invitrogen), 1× B27 (Invitrogen), 1.25 mM 
N-acetylcysteine (Sigma-Aldrich), epidermal growth factor (500 ng/ml) (Peprotech, 
Rocky Hill, NJ), 10% R-spondin1–Fc–conditioned medium, and Noggin (100 ng/ml) 
(Peprotech), was overlaid on the gel in each well. The cultures were then maintained in 
an incubator (37°C, 5% CO2). Images were obtained with a microscope (Axiovert 200; 
Carl Zeiss, Oberkochen, Germany).  
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Statistical analysis 
Disease activity was compared between mouse genotypes with the Wilcoxon rank-sum 
test. Other quantitative data are presented as means ± SE and were analyzed with 
Student’s t test, the Wilcoxon rank-sum test, or Welch’s t test as appropriate. All 
statistical analysis was performed with JMP software version 9.0 (SAS Institute, Cary, 
NC). A P value of <0.05 was considered statistically significant. 
 
Results 
Generation of IEC-specific Shp2 CKO mice 
To examine the impact of Shp2 ablation in IECs, we crossed mice homozygous for a 
floxed Ptpn11 allele [15] with those harboring a transgene for Cre recombinase under 
the control of the villin gene promoter (villin-cre) [18]. The specificity and efficiency of 
Ptpn11 deletion in adult Ptpn11fl/fl;villin-cre (Shp2 CKO) mice were determined by 
PCR analysis of genomic DNA isolated from the intestine as well as from other organs. 
Consistent with the results of previous studies with the villin-cre transgene [18], deleted 
Ptpn11 alleles were detected in the colon, ileum, jejunum, and duodenum of Shp2 CKO 
mice, but not in any other organ (Fig. 1A). We also confirmed that the activity of 
β-galactosidase was detected specifically in the entire epithelium of the ileum and colon 
of R26R;villin-cre mice (Fig. S1). Immunoblot analysis also showed that the abundance 
of Shp2 protein in isolated IECs from the ileum or colon of Shp2 CKO mice was greatly 
reduced compared with that for control mice, whereas it was unaffected in other organs 
(Fig. 1B). These results thus indicated that the villin-cre transgene directs the efficient 
and specific deletion of the Shp2 gene in IECs. 
Shp2 CKO mice develop severe colitis 
Shp2 CKO mice were born apparently healthy (data not shown), and they were 
phenotypically indistinguishable from control littermates at 2 weeks of age (Fig. 2A). 
However, both male and female Shp2 CKO mice manifested a marked reduction in 
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body weight as well as growth retardation compared with control littermates at 3 to 4 
weeks of age (Fig. 2A). They also manifested severe diarrhea. We evaluated disease 
activity for colitis on the basis of stool consistency, blood in the stool, and anorectal 
prolapse in both Shp2 CKO and control mice at 4 to 5 weeks of age. The disease 
activity index for Shp2 CKO mice was markedly greater than that for control animals 
(Fig. 2B). Furthermore, ~80% of Shp2 CKO mice died by 10 weeks of age (Fig. 2C).  
Histological examination of the colon from 3-week-old Shp2 CKO mice revealed 
pronounced inflammation in all regions from the cecum to the rectum (Fig. 3A). 
Epithelial hyperplasia was relatively prominent, and transmural inflammation with crypt 
abscesses was occasionally observed. Inflammatory infiltrates were also present in both 
the mucosa and submucosa. In contrast to the colon, most regions of the small intestine 
of Shp2 CKO mice were phenotypically indistinguishable from those of control mice, 
although abnormal structures of villi and mild inflammatory infiltrates were 
occasionally apparent. Together, these observations indicated that Shp2 ablation in IECs 
resulted in the spontaneous development of marked inflammation in the intestine, 
particularly in the colon.  
Marked reduction in the numbers of absorptive enterocytes and goblet cells in Shp2 
CKO mice 
We next examined the impact of IEC-specific Shp2 ablation on the numbers of 
absorptive enterocytes, mucin-secreting goblet cells, and antimicrobial 
peptide–producing Paneth cells in the intestinal epithelium. The number of absorptive 
enterocytes, which were identified on the basis of their morphology in tissue sections 
stained with a mAb to β-catenin [8], was markedly reduced in the ileum of Shp2 CKO 
mice at 3 to 4 weeks of age compared with that for control mice (Fig. 4A). We were not 
able to determine the precise number of absorptive enterocytes in the colon of Shp2 
CKO mice because of their severe colitis. In addition, the number of mucin 2–positive 
goblet cells was also reduced in the ileum as well as the colon of Shp2 CKO mice at 3 
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weeks of age (Fig. 4B). We were again unable to determine the precise number of 
goblet cells in the colon of Shp2 CKO mice as a result of their severe colitis. In contrast, 
the number of lysozyme-positive Paneth cells was slightly increased in the ileum of 
Shp2 CKO mice at 3 weeks of age (Fig. 4C). These results thus suggested that Shp2 is 
important for regulation of the numbers of absorptive enterocytes and goblet cells in the 
mouse intestine. 
We next investigated whether Shp2 regulates the size of the intestinal stem cell 
population, for which Olfm4 is a marker [24]. However, the number of Olfm4 
mRNA–positive cells in crypts of the ileum did not differ between Shp2 CKO and 
control mice at 3 to 4 weeks of age (Fig. 4D).  
Impaired migration of IECs in the ileum of Shp2 CKO mice  
Given the role of Shp2 in promotion of cell growth or survival [10], we next examined 
the incorporation of BrdU into IECs as well as the turnover of BrdU-labeled IECs in 
Shp2 CKO mice at 3 to 4 weeks of age. At 2 h after BrdU injection, the number of 
BrdU-positive IECs in crypts of the ileum (Fig. 5A) or colon (Fig. 5B) from Shp2 CKO 
mice was similar to that for control mice. At 2 days after BrdU injection, most 
BrdU-positive IECs in the ileum of control mice had reached the middle region or top of 
villi (Fig. 5C). In contrast, such migration of BrdU-positive IECs along the crypt-villus 
axis was markedly delayed in Shp2 CKO mice (Fig. 5C). These results thus suggested 
that Shp2 is dispensable for the proliferation of IECs, in particular for that of TA cells, 
in crypts of the ileum or colon, but that it is required for migration of IECs along the 
crypt-villus axis in the ileum.  
Absorptive enterocytes have a short life span (~5 days), being released into the 
gut lumen after they have migrated to the tip of villi. This elimination of IECs is thought 
to be triggered, at least in part, by spontaneous apoptosis [3]. To investigate whether the 
marked reduction in the numbers of absorptive enterocytes and goblet cells apparent in 
the intestine of Shp2 CKO mice might be attributable to an increased frequency of 
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apoptosis, we performed immunostaining with antibodies to the cleaved form of 
caspase-3. However, the number of cleaved caspase-3–positive IECs in the ileum or 
colon of Shp2 CKO mice did not differ significantly from that for control mice (Fig. 
S2).  
Impaired development of intestinal organoids from Shp2 CKO mice 
The effect of Shp2 ablation in IECs on the development of villus structure from isolated 
crypts was investigated with the use of intestinal crypt-villus organoids [5]. The 
development of intestinal organoids from Shp2 CKO mice was found to be markedly 
impaired compared with that for control mice (Fig. 6). One day after seeding of isolated 
crypts, the morphology of the cultured crypts from Shp2 CKO mice was 
indistinguishable from that for control mice. However, 7 days after seeding, most of the 
crypts isolated from Shp2 CKO mice had failed to develop into intestinal organoids; 
they instead shrank or became cell debris. Quantitative analysis revealed that, whereas 
66.6 ± 9.9% of crypts from control mice developed into intestinal organoids, only 21.1  
± 6.2% of those from Shp2 CKO mice did so. These results thus suggested that Shp2 is 
essential for efficient formation of intestinal organoids from isolated crypts.  
Expression of activated K-Ras in IECs protects Shp2 CKO mice against colitis 
Ras is an essential component of the signaling pathway by which growth factors 
stimulate cell proliferation, and the PTP activity of Shp2 is thought to regulate an 
upstream element necessary for Ras activation [10,11]. The phenotypes of Shp2 CKO 
mice were thus likely to be attributable at least in part to impairment of the activation of 
Ras in IECs. To examine this notion, we crossed Shp2 CKO mice with LSL-Kras G12D 
mice [17], which harbor a gene for an activated form of K-Ras (K-RasG12D). The 
crossing of Shp2 CKO (Ptpn11fl/fl;villin-cre) mice with LSL-Kras G12D mice results in 
removal of translational stop elements by Cre-mediated recombination and consequent 
expression of the K-RasG12D gene under the control of its endogenous regulatory 
elements in an IEC-specific manner. Shp2 CKO;LSL-Kras G12D mice were born 
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apparently healthy and phenotypically indistinguishable from their Shp2 CKO 
littermates (data not shown). Whereas Shp2 CKO mice were already sick at 4 weeks of 
age (Fig. 2), Shp2 CKO;LSL-Kras G12D mice (male or female) remained apparently 
healthy. Indeed, the body weight of Shp2 CKO;LSL-Kras G12D mice at 4 weeks of age 
was markedly greater than that of their Shp2 CKO littermates (Table 1), being similar 
to that of control mice (Fig. 2A). In addition, none of the Shp2 CKO;LSL-Kras G12D 
mice examined manifested any sign of colitis at or had died by 4.5 weeks of age (Table 
1). Consistent with these findings, histological analysis of the ileum or colon from Shp2 
CKO;LSL-Kras G12D mice revealed no sign of inflammation (Fig. 7A). These results 
thus suggested that expression of an active form of K-Ras in IECs protected Shp2 CKO 
mice from the development of colitis. We also found that the number of β-catenin 
–positive absorptive enterocytes was increased and that of Paneth cells was reduced in 
the ileum of Shp2 CKO;LSL-Kras G12D mice compared with those for Shp2 CKO mice 
at 4.5 weeks of age (Fig. 7B). In addition, we found that the number of mucin 
2–positive goblet cells in the ileum or colon of Shp2 CKO;LSL-Kras G12D mice at 4.5 
weeks of age was markedly greater than that for Shp2 CKO mice (Fig. 7C). The 
number of mucin 2–positive goblet cells in the ileum of Shp2 CKO;LSL-Kras G12D 
mice (22 ± 1 per villus) was similar to or even slightly greater than that apparent in 
control mice (18  1 per villus) (Fig. 4B). Together, these findings suggested that 
crossing of Shp2 CKO mice with LSL-Kras G12D mice restores the phenotypes of the 
former animals to normal. 
 
Discussion 
We have here shown that mice lacking Shp2 specifically in IECs develop severe colitis. 
The numbers of absorptive enterocytes and goblet cells were markedly reduced in the 
small intestine and colon of the mutant mice compared with those for control animals. 
Moreover, the development of intestinal organoids from isolated crypts of the Shp2 
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CKO mice was impaired. Shp2 is thought to be indispensable for activation of the 
Ras-MAPK signaling pathway and thereby for the promotion of cell proliferation and 
differentiation [10,11,25]. Shp2 in the nucleus is also important for activation of Wnt 
signaling [26], which is a key regulator of the proliferation and differentiation of IECs 
[2]. However, the colitis as well as the reduction in the number of absorptive 
enterocytes and goblet cells in the ileum of Shp2 CKO mice were prevented by 
expression of an activated form of K-Ras in IECs. Our present results thus indicate that 
Shp2 in IECs is important for protection against colitis as well as for homeostatic 
regulation of absorptive enterocytes and goblet cells, and that these functions of Shp2 
are mediated through activation of the Ras-MAPK signaling pathway. The development 
of intestinal organoids essentially requires epidermal growth factor, which promotes 
IEC growth by activation of Ras-MAPK signalling, in the culture medium [5]. Thus, the 
impaired development of organoids from isolated crypts of the Shp2 CKO mice is most 
likely attributable to the impaired effect of epidermal growth factor on organoid 
development. Moreover, such impaired development of organoids in the culture system 
is well consistent with the IEC phenotype of Shp2 CKO mice such as reduced numbers 
of absorptive enterocytes and goblet cells, two major cell populations in IECs.  
Shp2 is indispensable for embryogenesis at the early stages of gastrulation and 
mesoderm patterning [14]. In addition, conditional ablation of Shp2 in hematopoietic 
stem cells induces bone marrow aplasia [27], suggesting that Shp2 is essential for 
hematopoiesis from stem cells in the bone marrow. Given that Cre recombinase is 
expressed throughout the presumptive intestine of villin-cre mice by 14.5 days post 
coitum [18], ablation of Shp2 in the embryonic intestinal epithelium likely occurs in our 
Shp2 CKO mice. It is therefore of note that Shp2 CKO mice were born apparently 
healthy and that the overall development and morphology of the intestinal epithelium in 
these animals appeared almost normal up to 2 to 3 weeks of age (data not shown). 
Indeed, the population of Olfm4 mRNA–positive stem cells and BrdU incorporation 
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into TA cells in crypts were not significantly affected in the small intestine of Shp2 
CKO mice compared with control mice. Unlike the hematopoietic cell system, the 
Shp2-Ras signaling pathway thus does not appear to play a key role in the homeostasis 
of stem cells or in TA cell proliferation in the intestinal epithelium. In contrast, the Wnt 
signaling pathway is thought to be required for maintenance of intestinal stem cells as 
well as for the proliferation of IECs generated from these stem cells [2]. Indeed, 
ablation of the transcription factor Tcf-4, which is essential for operation of the Wnt 
signaling pathway in IECs, was found to result in marked defects in the development of 
intestinal villi, including the complete absence of the intestinal progenitor compartment 
[28].  
Our results indicate that the Shp2-Ras signaling pathway is important for the 
development of mature IECs, in particular for that of absorptive enterocytes and goblet 
cells. The number of absorptive enterocytes in the small intestine was markedly reduced 
in Shp2 CKO mice. In addition, the number of goblet cells was also reduced in both the 
small intestine and colon of Shp2 CKO mice. Consistent with this finding, activation of 
K-Ras in IECs was previously shown to result in hyperplasia of the intestinal epithelium 
(suggesting an increase of absorptive enterocytes) as well as a marked increase in the 
number of goblet cells [29,30]. Indeed, the reduction in the numbers of absorptive 
enterocytes and goblet cells in the ileum of Shp2 CKO mice was prevented by 
expression of an activated form of K-Ras in IECs. Thus, the Shp2-Ras signaling 
pathway is indeed important for the development of absorptive enterocytes and goblet 
cells. In contrast, Shp2 CKO mice manifested a significant increase in the number of 
Paneth cells in crypts. Conversely, we also showed that such increased number of 
Paneth cells was prevented by expression of an activated form of K-Ras in IECs. It was 
also showed that activation of K-Ras in IECs resulted in a marked reduction in the 
number of Paneth cells [30]. Thus, the Shp2-Ras signaling likely participates in 
negative regulation of the Paneth cell population.  
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The etiology of colitis in Shp2 CKO mice remains to be fully characterized. 
Goblet cells in the intestinal epithelium are thought to form a mucosal barrier by 
secreting mucus and thereby to protect against the development of intestinal 
inflammation [31]. Mucin 2 is the most abundant mucin produced by goblet cells, and 
deletion or mutation of the mucin 2 gene in mice results in the spontaneous 
development of colitis [32,33]. The development of intestinal inflammation in Shp2 
CKO mice is therefore most likely attributable to the marked reduction in the number of 
goblet cells in the intestine. Absorptive enterocytes are most abundant IECs and they 
form a physiological barrier against the intestinal microflora. We showed that the 
number of absorptive enterocytes was markedly reduced in Shp2 CKO mice, suggesting 
that the impairment of the physiological barrier provided by the intestinal epithelium 
likely occurs in Shp2 CKO mice. During the course of the present study, Coulombe et al. 
also showed that ablation of Shp2 in IECs resulted in the spontaneous development of 
colitis [34]. They also showed that expression of tight junctional proteins such as 
claudin was markedly reduced in the colon of their mutant mice, resulting in an increase 
in intestinal permeability [34]. Collectively, a defect in the physical barrier provided by 
the intestinal epithelium is likely a contributing factor to the development of colitis in 
Shp2 CKO mice. The number of Paneth cells was slightly increased in the ileum of 
Shp2 CKO mice. Paneth cells produce antimicrobial peptide such as α- or β-defensin, 
which are thought to be important for preventing the growth of pathogenic microbes 
[35,36]. Thus, the increase of Paneth cells unlikely participates in the development of 
colitis in Shp2 CKO mice. The prevention of epithelial cell death by conditional 
ablation of caspase-8 in mouse IECs was also found to induce intestinal inflammation 
[37], suggesting that proper turnover of these cells is also important for homeostasis of 
intestinal immunity. In the present study, we found that IEC-specific ablation of Shp2 
resulted in impaired migration of IECs along the crypt-villus axis. A delayed turnover 
of IECs may thus also contribute to intestinal inflammation in Shp2 CKO mice.  
 18 
In summary, we have shown that Shp2 is necessary for homeostasis of IECs, in 
particular for that of absorptive enterocytes and goblet cells, as well as for protection 
against colitis. These functions of Shp2 are likely mediated by activation of Ras. Further 
investigation will be required, however, to clarify the molecular mechanism by which 
Shp2 in IECs regulates intestinal immunity and protects against colitis. 
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FIGURE LEGENDS 
Figure 1. Generation of IEC-specific Shp2 CKO mice.  
A: Genomic DNA extracted from the indicated organs of adult control (Ctrl) or Shp2 
CKO (CKO) mice was subjected to PCR analysis with primers specific for deleted or 
floxed alleles of Ptpn11. Data are representative of three separate experiments. B: 
Lysates of IECs (from the ileum or colon) and the indicated organs from control or 
Shp2 CKO mice were subjected to immunoblot analysis with antibodies to (α-) both 
Shp2 and β-tubulin (loading control). Data are representative of three (IECs) or two 
(indicated organs) separate experiments. 
 
Figure 2. Shp2 CKO mice develop severe colitis. 
A: Body weight of 2-, 3-, or 4-week-old control (male, n = 23, 26, and 27, respectively; 
female, n = 22, 24, and 22, respectively) or Shp2 CKO (male, n = 17, 20, and 16, 
respectively; female, n = 15, 15, and 13, respectively) mice is shown in the left panel. 
Data are means ± SE. *P < 0.05, ***P < 0.0001 (Welch’s t test). N.S., not significant. 
Representative photographs of control and Shp2 CKO mice at 5 weeks of age are shown 
in the right panel. Scale bar, 1 cm. B: Disease activity index (DAI) for colitis in control 
(n = 19) and Shp2 CKO (n = 11) mice at 4 to 5 weeks of age. Bars indicate median 
scores. ***P < 0.0001 (Wilcoxon rank-sum test). C: Survival rates of control (n = 19) 
and Shp2 CKO (n = 17) mice. 
 
Figure 3. Spontaneous development of marked inflammation in the colon of Shp2 
CKO mice. 
A: Hematoxylin-eosin staining of paraffin-embedded sections of the cecum, mid-colon, 
and rectum from control or Shp2 CKO mice at 3 weeks of age. Arrowheads and the 
asterisk indicate inflammatory infiltrates and a crypt abscess, respectively. B: 
Hematoxylin-eosin staining of the ileum from control and Shp2 CKO mice at 3 weeks 
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of age. Arrowheads and the arrow indicate inflammatory infiltrates and abnormal villus 
structure, respectively. All data are representative of three separate experiments. Scale 
bars, 100 μm. 
 
Figure 4. Marked reduction in the numbers of absorptive enterocytes and goblet cells 
in Shp2 CKO mice. 
A: Frozen sections of the ileum from control or Shp2 CKO mice at 3 to 4 weeks of age 
were immunostained with an antibody to β-catenin (green) and also stained with DAPI 
(blue). Representative images are shown in the left panel. Arrowheads indicate 
β-catenin–positive absorptive enterocytes. Scale bar, 100 μm. The number of 
β-catenin–positive absorptive enterocytes per villus was determined for the ileum (right 
panel). Data are means ± SE for 38 (control) or 32 (Shp2 CKO) villi from a total of 
three mice per group. ***P < 0.0001 (Welch’s t test). B: Frozen sections of the ileum 
and colon from control or Shp2 CKO mice at 3 weeks of age were immunostained with 
antibodies to mucin 2 (red) and to β-catenin (green). Representative images are shown 
in the left panel. Scale bar, 100 μm. The number of mucin 2 (Muc2)–positive goblet 
cells per villus was determined for the ileum (right panel). Data are means ± SE for 100 
(control) or 93 (Shp2 CKO) villi from a total of three mice per group. ***P < 0.0001 
(Welch’s t test). C: Frozen sections of the ileum from control or Shp2 CKO mice at 3 
weeks of age were subjected to immunostaining with antibodies to lysozyme (red) and 
to β-catenin (green) as well as to staining of nuclei with DAPI (blue). Representative 
images are shown in the left panel. Scale bar, 50 μm. The number of lysozyme-positive 
Paneth cells per crypt was determined (right panel). Data are means ± SE for 150 crypts 
from a total of three mice per group. **P < 0.01 (Student’s t test). D: Paraffin sections 
of the ileum from control or Shp2 CKO mice at 3 to 4 weeks of age were subjected to in 
situ hybridization analysis of Olfm4 mRNA. Representative images are shown in the 
left panel. Scale bar, 50 μm. The number of Olfm4 mRNA–positive cells per crypt was 
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determined (right panel). Data are means ± SE for 60 crypts from a total of two mice per 
group. N.S., not significant (Student’s t test). 
 
Figure 5. Impaired migration of IECs along the crypt-villus axis in the ileum of Shp2 
CKO mice. 
A: Frozen sections of the ileum from 3- to 4-week-old control or Shp2 CKO mice at 2 h 
after BrdU injection were immunostained with mAbs to BrdU (red) and to β-catenin 
(green). Representative images are shown in the left panel. The number of 
BrdU-positive cells per crypt was determined (right panel). Data are means ± SE for 54 
(control) or 77 (Shp2 CKO) crypts from a total of three (control) or four (Shp2 CKO) 
mice per group. N.S., not significant (Student’s t test). B: Frozen sections of the colon 
from 3- to 4-week-old control or Shp2 CKO mice at 2 h after BrdU injection were 
immunostained as in A. The number of BrdU-positive cells per crypt was determined. 
Quantitative data are means ± SE for 54 (control) or 47 (Shp2 CKO) crypts from a total 
of three mice per group. N.S., not significant (Wilcoxon rank-sum test). C: Frozen 
sections of the ileum from 3- to 4-week-old control or Shp2 CKO mice at 2 days after 
BrdU injection were immunostained as in A. The distance from the crypt base to the 
farthest migrated BrdU-positive cells was measured. Quantitative data are means ± SE 
for 40 (control) or 48 (Shp2 CKO) villi from a total of three mice per group. 
***P < 0.0001 (Student’s t test). All scale bars are 100 μm. 
 
Figure 6. Impaired development of intestinal organoids from Shp2 CKO mice. 
Representative images of intestinal organoids derived from the jejunum of control or 
Shp2 CKO mice at 1 and 7 days after plating are shown in the left panel. Scale bar, 100 
μm. The number of intestinal organoids with a crypt-villus structure at 7 days after 
plating was determined as a percentage of those with a spherelike morphology (diameter 
of >30 μm) at 1 day (right panel). Data are means ± SE for a total of 151 (control) or 
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128 (Shp2 CKO) organoids in four independent experiments. **P < 0.01 (Student’s t 
test). 
 
Figure 7. Expression of activated K-Ras in IECs protects Shp2 CKO mice against 
colitis. 
A: Hematoxylin-eosin staining of the ileum and colon from Shp2 CKO;LSL-Kras G12D 
mice at 4.5 weeks of age. Images are representative of those from three mice. Scale bar, 
100 μm. B: Frozen sections of the ileum and colon from Shp2 CKO;LSL-Kras G12D 
(CKO/G12D) mice and their Shp2 CKO littermates at 4.5 weeks of age were 
immunostained with antibodies to lysozyme (red) and to β-catenin (green). 
Representative images are shown in the left panel. Scale bar, 100 μm. The middle panel 
shows the number of β-catenin –positive absorptive enterocytes per villus of the ileum. 
Data are means ± SE for 14 (CKO/G12D) or 10 (CKO) villi from a total of three 
(CKO/G12D) or two (CKO) mice per group. *P < 0.05 (Student’s t test). The right 
panel shows lysozyme-positive Paneth cells per crypt of the ileum. Data are means ± SE 
for 60 (CKO/G12D) or 43 (CKO) crypts from a total of three (CKO/G12D) or two 
(CKO) mice per group. ***P < 0.0001 (Student’s t test). C: Frozen sections of the 
ileum and colon from Shp2 CKO;LSL-Kras G12D (CKO/G12D) mice and their Shp2 
CKO littermates at 4.5 weeks of age were immunostained with antibodies to mucin 2 
(red) and to β-catenin (green). Representative images are shown in the left panel. Scale 
bar, 100 μm. The number of mucin 2–positive goblet cells per villus of the ileum was 
determined (right panel). Data are means ± SE for 30 (CKO/G12D) or 21 (CKO) villi 
from a total of three (CKO/G12D) or two (CKO) mice per group. ***P < 0.0001 
(Welch’s t test). 
 
Supporting Information 
Figure S1. Specific expression of β-galactosidase in the ileum and colon of 
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R26R;villin-cre mice. 
Frozen sections of the ileum or colon from adult R26R;villin-cre mice were stained for 
β-galactosidase activity (blue). Scale bar, 100 μm. 
 
Figure S2. Lack of effect of Shp2 ablation on the number of apoptotic IECs in the 
ileum or colon.  
Frozen sections of the ileum (A) or colon (B) from control or Shp2 CKO mice at 3 
weeks of age were immunostained with antibodies to cleaved caspase-3 (red) and to 
β-catenin (green). Representative images are shown in the left panels. Scale bars, 100 
μm. The number of cleaved caspase-3–positive cells per 10 villi in the ileum or 10 
intestinal glands in the colon was determined (right panels). Data are means ± SE for 
104 (control) or 118 (Shp2 KO) villi of the ileum and for 95 (control) or 92 (Shp2 
CKO) intestinal glands of the colon from a total of two mice per group. N.S., not 
significant (Wilcoxon rank-sum test). 
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Table 1. Phenotypes of three Shp2 CKO;LSL-Kras G12D mice and three Shp2 
CKO littermates at 4.5 weeks of age 
 
Genotype Sex Body weight (g) Disease activity index 
CKO Male 5.8 Dead 
CKO Male 7.5 6 
CKO Female 7.6 2 
CKO/Kras G12D Male 9.2 0 
CKO/Kras G12D Female 10.3 0 
CKO/Kras G12D Female 11.8 0 
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